Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-
 
WKN: A2PJ6N / Name: Advanced / Stock / Biotechnology & Medical Research / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Advanced Proteome Therapeutics Stock

Pros and Cons of Advanced Proteome Therapeutics in the next few years

Pros
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Advanced Proteome Therapeutics vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Advanced Proteome Therapeutics - - - - - - -
Larimar Therapeutics Inc. -0.630% 4.575% 8.108% 53.846% -3.614% 8.108% -56.757%
Northwest Biotherapeutics Inc. 0.000% 4.242% -14.000% -25.217% -16.505% -67.850% -85.785%
Celldex Therapeutics 1.320% 4.080% 10.096% 63.257% 29.864% -13.946% 13.283%

News

This Artificial Intelligence (AI) Chip Stock Is Dominating the Inference Era. It Could Be the Biggest Winner of This Megatrend (Hint: It's Not AMD or Broadcom): https://g.foolcdn.com/editorial/images/875796/nvda_tmf.png
This Artificial Intelligence (AI) Chip Stock Is Dominating the Inference Era. It Could Be the Biggest Winner of This Megatrend (Hint: It's Not AMD or Broadcom)

Artificial intelligence (AI) is moving from the training phase to the production phase, as enterprises, users, and governments that have spent hundreds of billions of dollars on this technology are

Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus

Key Points

Nvidia vs. Advanced Micro Devices: What Do Their Revenue Trends Tell Investors?: https://g.foolcdn.com/charts/production/processed/nvda-amd/quarter/revenue/bar/primary/standard/limit-8/latest/nvda-amd_quarter_revenue_bar_primary_standard_limit8.png
Nvidia vs. Advanced Micro Devices: What Do Their Revenue Trends Tell Investors?

Nvidia (NASDAQ:NVDA) primarily generates its revenue by providing advanced graphics, computational, and networking solutions.

It announced that its Vera Rubin platform entered full production on